Non-alcoholic fatty liver disease following liver transplantation: a clinical review.

摘要: Non-alcoholic steatohepatitis (NASH) is rapidly becoming the leading indication for liver transplantation (LT) in United States. While post-transplantation outcomes are similar to other indications transplant, recent evidence has suggested that reduction risk factors post-transplant metabolic syndrome may impose a significant survival benefit this patient population. Cardiovascular mortality cause of death following NASH. pre-transplant pharmacologic and surgical approaches have been utilized reduce cardiovascular transplantation, effectiveness these treatment setting poorly defined. Studies urgently needed growing